MeSH tree: C04.557.470.670.380.515
A study of newly created databases of medulloblastoma has found that patients with tumors containing circular extrachromosomal DNA—loops of DNA found outside of regular chromosomes—are twice as likely to relapse and three ...
Nov 14, 2023
0
46
Most new cancer cases are treated with chemotherapy, but humans naturally express proteins that indiscriminately remove chemotherapy drugs from many cells—including tumor cells, which reduces treatment efficacy.
Aug 21, 2023
0
45
Researchers at Uppsala university have developed a new method to find mutations in brain tumors in children. They also showed that the mutations change how cancer cells respond to a cancer drug. These findings could lead ...
Aug 7, 2023
0
54
A new editorial paper titled "Targeting H3K27me3 loss in pediatric brain tumors—a perspective on epigenetically guided cancer therapy" has been published in Oncotarget.
Aug 2, 2023
0
65
From neurological problems to hearing loss and infertility, survivors of medulloblastoma, an aggressive form of brain cancer, are left with severe physical and cognitive impairments and have an overall mortality rate 21 times ...
Mar 28, 2023
0
49
Research from Johns Hopkins Kimmel Cancer Center experts revealed a type of RNA, previously considered to be "junk," that may help doctors distinguish and treat a subgroup of patients with medulloblastoma.
Mar 23, 2023
0
46
New research pinpoints a key cause of metastasis from an aggressive form of brain cancer in children and provides a potential new therapy for treating these tumors in the future.
Mar 6, 2023
0
78
A new research perspective was published in Oncotarget. The paper is titled "WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?"
Feb 27, 2023
0
28
A new research perspective titled "Intraventricular immunovirotherapy; a translational step forward" has been published in Oncotarget.
Jan 26, 2023
0
43
An enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster University-led study.
Nov 10, 2022
0
49
